TTM
−$74.31M
YoY change
+2.9%
5Y CAGR
—
Peak year (2021)
−$9.19M
Cumulative net income
−$224.11M
Net Income history chart for Alto Neuroscience (ANRO) from 2021 to 2025
Latest: −$63.24M
Net Income growth chart for Alto Neuroscience (ANRO) from 2021 to 2025
Latest: +2.9%
Net Income history table for Alto Neuroscience (ANRO) from 2021 to 2025
| 2025 | −$63.24M | +2.9% | −$1.81M | ||
| 2024 | −$61.43M | +69.2% | −$25.13M | ||
| 2023 | −$36.30M | +31.0% | −$8.60M | ||
| 2022 | −$27.71M | +201.6% | −$18.52M | ||
| 2021 | −$9.19M | — | — |
- 2025−$63.24M+2.9%
- 2024−$61.43M+69.2%
- 2023−$36.30M+31.0%
- 2022−$27.71M+201.6%
- 2021−$9.19M—
Net Income values are taken from Alto Neuroscience's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at Alto Neuroscience (ANRO)
According to Alto Neuroscience's latest reported financial statements, the company's current net income (TTM) is −$74.31M. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Alto Neuroscience (ANRO) reported net income of −$63.24M – edged up 2.9% year-over-year.
The record annual net income stands at −$9.19M, reached in 2021; the historical low of −$63.24M was recorded in 2025.
Alto Neuroscience Net Income by Year
Alto Neuroscience Net Income 2025: −$63.24M
In 2025, Alto Neuroscience reported net income of −$63.24M, edged up 2.9% from 2024. This figure represents the lowest annual value in the available history.
Alto Neuroscience Net Income 2024: −$61.43M
Alto Neuroscience net income in 2024 was −$61.43M, surged 69.2% from 2023.
Alto Neuroscience Net Income 2023: −$36.30M
2023's net income for Alto Neuroscience came in at −$36.30M, surged 31.0% from 2022.
Alto Neuroscience Net Income 2022: −$27.71M
Alto Neuroscience posted net income of −$27.71M in 2022, surged 201.6% from 2021.
Alto Neuroscience Net Income 2021: −$9.19M
Alto Neuroscience net income in 2021 was −$9.19M.
See more financial history for Alto Neuroscience (ANRO).
Sector peers by Net Income
Healthcare peers of Alto Neuroscience (ANRO), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $4.23B |
- $26.80B
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $7.71B
- $4.23B
Frequently asked questions
Alto Neuroscience (ANRO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation